RDHL - レッドヒル・バイオファ―マ (Redhill Biopharma Ltd.) レッドヒル・バイオファ―マ

 RDHLのチャート


 RDHLの企業情報

symbol RDHL
会社名 Redhill Biopharma Ltd Ramat Gan (レッドヒル・バイオファ―マ)
分野(sector) Health Care   ヘルスケア
産業(industry) Major Pharmaceuticals  
業種    医療関連(Health Care)
概要 事業概要 --   レッドヒル・バイオファ―マは、イスラエルのバイオ製薬会社。胃腸癌を含む炎症性および胃腸疾患の治療用に、後期の臨床段階にある独自の経口投与薬剤を開発、買収に注力する。イスラエル、米国、カナダ、欧州で事業を展開。同社の製品パイプラインは、後期の臨床段階にある8薬の治療候補で構成される。   RedHill Biopharma Ltd. is a biopharmaceutical company focusing on the development and commercialization of proprietary drugs for the treatment of gastrointestinal diseases. It operates through the Commercial Operations segment and the Research & Development segment. The Commercial Operations segment covers all areas relating to the commercial sales and operating expenses directly related to that activity and is being performed by the Company's subsidiary in the United States. The Research & Development segment includes all activities related to the research and development of therapeutic candidates. The company was founded by Dror Ben-Asher and Ori Shilo on August 3, 2009 and is headquartered in Tel Aviv, Israel.
本社所在地 21 Ha'arba'a Street Tel-Aviv 64739 ISR
代表者氏名
代表者役職名
電話番号
設立年月日 40026
市場名 NASDAQ Small Cap
ipoyear ―年
従業員数 74人
url www.redhillbio.com
nasdaq_url https://www.nasdaq.com/symbol/rdhl
adr_tso 15297124
EBITDA EBITDA ー
終値(lastsale) 8.38
時価総額(marketcap) 128189899.12
時価総額 時価総額 ―
売上高 売上高 --
企業価値(EV) 企業価値(EV) ー
当期純利益 当期純利益 --
決算概要 決算概要 --

 RDHLのテクニカル分析


 RDHLのニュース

   RedHill's Oncology Candidate to be Tested for Coronavirus  2020/04/21 16:19:00 Zacks Investment Research
RedHill (RDHL) inks a deal with NIAID for non-clinical testing of its investigational candidate RHB-107 to evaluate its activity against COVID-19. Stock up.
   RedHill (RDHL) Soars: Stock Adds 9.2% in Session  2020/04/15 12:44:00 Zacks Investment Research
RedHill (RDHL) saw a big move last session, as its shares jumped more than 9% on the day, amid huge volumes.
   Stock Alert: RedHill Biopharma Shares Soar In Pre-Market  2020/03/11 08:06:00 RTT News
RedHill Biopharma Ltd. (RDHL) shares are rising above 5% in pre-market today, after the company said it is actively pursuing an exploratory program intended to evaluate the activity of opaganib and RHB-107, individually and in combination with hydroxychloroquine and other compounds in the treatment of COVID-19.
   RedHill EPS beats by $0.74, misses on revenue  2020/03/04 12:13:07 Seeking Alpha
RedHill (NASDAQ:RDHL): FY GAAP EPS of -$0.14 beats by $0.74. Revenue of $6.29M (-24.8% Y/Y) misses by $0.59M. Shares +0.93% PM. Press Release
   The Daily Biotech Pulse: Moderna Ships COVID-19 Vaccine For Clinics, Mallinckrodt Strikes $1.6B Opioid Settlement  2020/02/25 13:28:09 Benzinga
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week highs on Feb. 24) Avadel Pharmaceuticals PLC (NASDAQ: AVDL ) Brainstorm Cell Therapeutics Inc (NASDAQ: BCLI ) Co-Diagnostics Inc (NASDAQ: CODX )(received CE mark for its coronavirus test) COLLPLANT BIOTE/S ADR (NASDAQ: CLGN ) Gilead Sciences, Inc. (NASDAQ: GILD )(reacted to a statement from WHO that its experimental drug remdesivir could be the one drug that may have efficacy) NGM Biopharmaceuticals Inc (NASDAQ: NGM )( reacted to positive readout for its NASH drug) PAVmed Inc (NASDAQ: PAVM ) TELA Bio Inc (NASDAQ: TELA ) Zynex Inc. (NASDAQ: ZYXI ) Down In The Dumps (Biotech Stocks Hitting 52-week lows on Feb. 24) AcelRx Pharmaceuticals Inc (NASDAQ: ACRX ) Acorda Therapeutics Inc (NASDAQ: ACOR ) ADDEX THERAPEUT/ADR (NASDAQ: ADXN ) AngioDynamics, Inc. (NASDAQ: ANGO ) BioSig Technologies Inc (NASDAQ: BSGM ) Enanta Pharmaceuticals Inc (NASDAQ: ENTA ) Endologix, Inc.
   RedHill (RDHL) Soars: Stock Adds 9.2% in Session  2020/04/15 12:44:00 Zacks Investment Research
RedHill (RDHL) saw a big move last session, as its shares jumped more than 9% on the day, amid huge volumes.
   Stock Alert: RedHill Biopharma Shares Soar In Pre-Market  2020/03/11 08:06:00 RTT News
RedHill Biopharma Ltd. (RDHL) shares are rising above 5% in pre-market today, after the company said it is actively pursuing an exploratory program intended to evaluate the activity of opaganib and RHB-107, individually and in combination with hydroxychloroquine and other compounds in the treatment of COVID-19.
   RedHill EPS beats by $0.74, misses on revenue  2020/03/04 12:13:07 Seeking Alpha
RedHill (NASDAQ:RDHL): FY GAAP EPS of -$0.14 beats by $0.74. Revenue of $6.29M (-24.8% Y/Y) misses by $0.59M. Shares +0.93% PM. Press Release
   The Daily Biotech Pulse: Moderna Ships COVID-19 Vaccine For Clinics, Mallinckrodt Strikes $1.6B Opioid Settlement  2020/02/25 13:28:09 Benzinga
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week highs on Feb. 24) Avadel Pharmaceuticals PLC (NASDAQ: AVDL ) Brainstorm Cell Therapeutics Inc (NASDAQ: BCLI ) Co-Diagnostics Inc (NASDAQ: CODX )(received CE mark for its coronavirus test) COLLPLANT BIOTE/S ADR (NASDAQ: CLGN ) Gilead Sciences, Inc. (NASDAQ: GILD )(reacted to a statement from WHO that its experimental drug remdesivir could be the one drug that may have efficacy) NGM Biopharmaceuticals Inc (NASDAQ: NGM )( reacted to positive readout for its NASH drug) PAVmed Inc (NASDAQ: PAVM ) TELA Bio Inc (NASDAQ: TELA ) Zynex Inc. (NASDAQ: ZYXI ) Down In The Dumps (Biotech Stocks Hitting 52-week lows on Feb. 24) AcelRx Pharmaceuticals Inc (NASDAQ: ACRX ) Acorda Therapeutics Inc (NASDAQ: ACOR ) ADDEX THERAPEUT/ADR (NASDAQ: ADXN ) AngioDynamics, Inc. (NASDAQ: ANGO ) BioSig Technologies Inc (NASDAQ: BSGM ) Enanta Pharmaceuticals Inc (NASDAQ: ENTA ) Endologix, Inc.
   RedHill Biopharma buys rights to Movantik from AstraZeneca  2020/02/25 13:09:40 Seeking Alpha
RedHill Biopharma (NASDAQ:RDHL) says it is acquiring the global rights to Movantik (naloxegol), a peripherally acting mu-opioid receptor antagonist indicat
   Stock Alert: RedHill Biopharma Shares Soar In Pre-Market  2020/03/11 08:06:00 RTT News
RedHill Biopharma Ltd. (RDHL) shares are rising above 5% in pre-market today, after the company said it is actively pursuing an exploratory program intended to evaluate the activity of opaganib and RHB-107, individually and in combination with hydroxychloroquine and other compounds in the treatment of COVID-19.
   RedHill EPS beats by $0.74, misses on revenue  2020/03/04 12:13:07 Seeking Alpha
RedHill (NASDAQ:RDHL): FY GAAP EPS of -$0.14 beats by $0.74. Revenue of $6.29M (-24.8% Y/Y) misses by $0.59M. Shares +0.93% PM. Press Release
   The Daily Biotech Pulse: Moderna Ships COVID-19 Vaccine For Clinics, Mallinckrodt Strikes $1.6B Opioid Settlement  2020/02/25 13:28:09 Benzinga
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week highs on Feb. 24) Avadel Pharmaceuticals PLC (NASDAQ: AVDL ) Brainstorm Cell Therapeutics Inc (NASDAQ: BCLI ) Co-Diagnostics Inc (NASDAQ: CODX )(received CE mark for its coronavirus test) COLLPLANT BIOTE/S ADR (NASDAQ: CLGN ) Gilead Sciences, Inc. (NASDAQ: GILD )(reacted to a statement from WHO that its experimental drug remdesivir could be the one drug that may have efficacy) NGM Biopharmaceuticals Inc (NASDAQ: NGM )( reacted to positive readout for its NASH drug) PAVmed Inc (NASDAQ: PAVM ) TELA Bio Inc (NASDAQ: TELA ) Zynex Inc. (NASDAQ: ZYXI ) Down In The Dumps (Biotech Stocks Hitting 52-week lows on Feb. 24) AcelRx Pharmaceuticals Inc (NASDAQ: ACRX ) Acorda Therapeutics Inc (NASDAQ: ACOR ) ADDEX THERAPEUT/ADR (NASDAQ: ADXN ) AngioDynamics, Inc. (NASDAQ: ANGO ) BioSig Technologies Inc (NASDAQ: BSGM ) Enanta Pharmaceuticals Inc (NASDAQ: ENTA ) Endologix, Inc.
   RedHill Biopharma buys rights to Movantik from AstraZeneca  2020/02/25 13:09:40 Seeking Alpha
RedHill Biopharma (NASDAQ:RDHL) says it is acquiring the global rights to Movantik (naloxegol), a peripherally acting mu-opioid receptor antagonist indicat
   RedHill Biopharma to Discontinue Promotion of Legacy Products  2020/01/21 14:14:42 Investing News Network
RedHill Biopharma is discontining its commercialization agreements for its legacy products and focusing on its lead commercial products. The post RedHill Biopharma to Discontinue Promotion of Legacy Products appeared first on Investing News Network .

 関連キーワード  (― 米国株 レッドヒル・バイオファ―マ RDHL Redhill Biopharma Ltd.)

 twitter  (公式ツイッターやCEOツイッターなど)